MyFinsight
Home
Blog
About
Cash and cash
equivalents
$510,052K
(-29.30%↓ Y/Y)
Research and development
incentives receivable
$47,419K
(-21.95%↓ Y/Y)
Prepaid expenses and
other current assets
$17,765K
(-19.46%↓ Y/Y)
Total current assets
$575,236K
(-28.48%↓ Y/Y)
Operating lease
right-of-use assets
$13,979K
(140.77%↑ Y/Y)
Other assets
$12,668K
(-8.26%↓ Y/Y)
Property and equipment,
net
$4,695K
(-43.48%↓ Y/Y)
Total assets
$606,578K
(-27.11%↓ Y/Y)
Total liabilities and
shareholders' equity
$606,578K
(-27.11%↓ Y/Y)
Total shareholders'
equity
$510,255K
(-23.72%↓ Y/Y)
Total liabilities
$96,323K
(-41.00%↓ Y/Y)
Accumulated deficit
-$1,010,909K
(-23.21%↓ Y/Y)
Accumulated other
comprehensive loss
-$5,416K
(-61.05%↓ Y/Y)
Additional paid-in capital
$1,525,680K
(2.27%↑ Y/Y)
Total current
liabilities
$47,635K
(-38.47%↓ Y/Y)
Deferred revenue, net of
current portion
$34,077K
(-58.92%↓ Y/Y)
Operating lease
liabilities, net of current...
$13,680K
(675.07%↑ Y/Y)
Other long-term
liabilities
$931K
(-18.26%↓ Y/Y)
Ordinary shares,
including non-voting...
$900K
(0.78%↑ Y/Y)
Accrued expenses and
other current...
$39,094K
(-12.22%↓ Y/Y)
Accounts payable
$5,662K
(-69.00%↓ Y/Y)
Deferred revenue,
current portion
$2,879K
(-80.31%↓ Y/Y)
Back
Back
Balance Sheet
BICYCLE THERAPEUTICS PLC (BCYC)
BICYCLE THERAPEUTICS PLC (BCYC)
source: myfinsight.com